The Board of Directors of the Atlanpole Biotherapies cluster elected on September 21, 2021 for 3 years
Board of Atlanpole Biotherapies
- President : Franck GRIMAUD – Valneva
- Executive vice-president : Jean-François BALDUCCHI – Atlanpole
- Vice-president Immunotherapies : Maryvonne HIANCE – OSE Immunotherapeutics
- Vice-president Regenerative medicine : Franck ZAL – Hemarina
- Vice-president Radiopharmaceuticals : Ferid HADDAD – GIP Arronax
- Vice-president Clinical : Benoit Labarthe – CHU de Nantes
- Vice-president External relations : Olivier BOISTEAU – Clean Biologics
- Vice-president Academic : Charles PINEAU – Université de Rennes 1
- Treasurer : Serge RICHARD – ERBC Baugy Facility
- Secretary : Louis-Marie BACHELOT – GlioCure
Private College
- Louis-Marie Bachelot – GLIOCURE
- Olivier Boisteau – CLEAN BIOLOGICS
- Pascal Breton – WAVEIMPLANT
- Benoit Fouchaq – BIOFORTIS
- Philippe Gaudin – THERMO FISHER SCIENTIFIC
- Franck Grimaud – VALNEVA
- Maryvonne Hiance – OSE IMMUNOTHERAPEUTICS
- Ronan Le Bot – ATLANTA
- Noël Minard – DATACEND
- Serge Richard – ERBC BAUGY FACILITY
- Marwan Touati – PAREAN BIOTECHNOLOGIES
- Franck Zal – HEMARINA
Higher education schools, research and care College
- Loïc Carballido – CHU D’ANGERS
- Patrick Emond – UNIVERSITÉ DE TOURS
- Férid Haddad – GIP ARRONAX
- Frédéric Jacquemin – UNIVERSITÉ DE NANTES
- Benoît Labarthe – CHU DE NANTES
- Sidonie Lavergne – INSTITUT DE CANCÉROLOGIE DE L’OUEST
- Charles Pineau – UNIVERSITÉ DE RENNES 1
- Pascal Richomme-Peniguel – UNIVERSITÉ D’ANGERS
Economic development structures College
- Jean-François Balducchi – ATLANPOLE
- Hélène Le Pocher – BIOTECH SANTÉ BRETAGNE
- Quentin Renoul – ANGERS TECHNOPOLE
- Fabien Riolet – POLEPHARMA